Transcriptomic profiling of mouse primary BCC tumor-derived organoids following Il1a and Osm combination treatment demonstrated genome-wide changes consistent with those observed in mouse BCC cell line (Supplementary Figs. 7a, b). Here, OSM is linked to skin basal cell carcinoma.